IMARC Group, a leading market research company, has recently releases report titled “Surrogacy Market Report by Type (Gestational Surrogacy, Traditional Surrogacy), Technology (IVF with ICSI, IVF without ICSI, Intrauterine Insemination), Service Provider (Hospitals, Fertility Clinics, and Others), and Region 2024-2032”, Offers a comprehensive analysis of the industry, which comprises insights on the global surrogacy market.
How Big Is the Surrogacy Market?
The global surrogacy market size reached US$ 183.4 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 306.9 Million by 2032, exhibiting a growth rate (CAGR) of 5.8% during 2024-2032.
Factors Affecting the Growth of the Surrogacy Industry:
- Increasing Acceptance and Legalization:
The gradual shift in societal attitudes towards surrogacy, coupled with the legalization of surrogacy in more jurisdictions, is a significant driver of the global surrogacy market. As infertility becomes less stigmatized, more individuals and couples are exploring alternative family-building options, including surrogacy. Legalization efforts provide a framework for regulating surrogacy arrangements, offering clarity and protection for all parties involved. This increased acceptance and legal recognition not only drive demand for surrogacy services but also encourage the establishment of reputable surrogacy agencies and clinics, contributing to market growth and fostering a safer and more transparent surrogacy industry.
- Advancements in Assisted Reproductive Technologies (ART):
Technological innovations in ART have revolutionized the field of reproductive medicine, significantly improving the success rates of surrogacy procedures. Techniques such as in vitro fertilization (IVF) with intracytoplasmic sperm injection (ICSI) and preimplantation genetic testing have enhanced embryo quality and selection, increasing the likelihood of successful pregnancies via surrogacy. These advancements have also expanded the pool of potential surrogates and intended parents by offering solutions for individuals and couples with various fertility challenges. As ART continues to evolve, with ongoing research and development, the effectiveness and accessibility of surrogacy services are expected to further improve, driving market growth and adoption.
- Increasing Globalization and Accessibility:
The globalization of healthcare services, along with advancements in transportation and communication, has facilitated the globalization of the surrogacy market. Intended parents now have access to surrogacy services across borders, with a growing number of destination countries offering surrogacy programs. This increased accessibility has broadened the options available to individuals and couples seeking surrogacy, allowing them to choose destinations based on factors such as legal regulations, cost, and cultural compatibility. Moreover, globalization has fostered competition among surrogacy providers, leading to innovation, improved services, and greater transparency in the industry. As surrogacy becomes more accessible and widely accepted on a global scale, the market is poised for continued growth and diversification.
For an in-depth analysis, you can refer sample copy of the report : https://www.imarcgroup.com/surrogacy-market/requestsample
Leading Companies Operating in the Global Surrogacy Industry:
- Bourn Hall Clinic
- CARE Fertility
- Circle Surrogacy & Egg Donation
- Extraordinary Conceptions
- Growing Generations LLC
- Houston Fertility Center
- IVIRMA Global
- Max Healthcare
- New Hope Fertility Center
- Nova IVF
- Ovation Fertility
- Scanfert Clinic
Surrogacy Market Report Segmentation:
By Type:
- Gestational Surrogacy
- Traditional Surrogacy
Gestational surrogacy represents the leading segment due to its higher success rates and lower risk of genetic complications compared to traditional surrogacy.
By Technology:
- IVF with ICSI
- IVF without ICSI
- Intrauterine Insemination
IVF with ICSI accounts for the largest market share owing to its effectiveness in addressing various infertility issues and increasing the chances of successful implantation during gestational surrogacy procedures.
By Service Provider:
- Hospitals
- Fertility Clinics
- Others
Fertility clinics represent the largest segment as they offer comprehensive services ranging from initial consultation to embryo transfer, ensuring proper medical supervision and support throughout the surrogacy process.
Regional Insights:
- North America: (United States, Canada)
- Asia Pacific: (China, Japan, India, South Korea, Australia, Indonesia, Others)
- Europe: (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
- Latin America: (Brazil, Mexico, Others)
- Middle East and Africa
North America's dominance in the surrogacy market is attributed to its advanced healthcare infrastructure, favorable regulatory environment, and higher acceptance of assisted reproductive technologies.
Global Surrogacy Market Trends:
The global surrogacy market is primarily driven by increasing acceptance and legalization of surrogacy worldwide that has led to a shift in societal attitudes towards alternative family-building options. Apart from this, ongoing technological advancements in assisted reproductive technologies (ART), such as IVF with ICSI and preimplantation genetic testing, have significantly improved success rates, expanding the pool of potential surrogates and intended parents.
Additionally, the globalization of healthcare services has facilitated the accessibility of surrogacy across borders, allowing individuals and couples to choose from a wider range of destination countries, thus propelling market growth.
If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC Group’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact US:
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
United States: +1-631-791-1145 | United Kingdom: +44-753-713-2163
